Comparison of efficacy and safety of intracoronary sodium nitroprusside and intravenous adenosine for assessing fractional flow reserve
- 15 October 2012
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 81 (3), 540-544
- https://doi.org/10.1002/ccd.24652
Abstract
Objectives The purpose of this study was to compare the efficacy and safety of intracoronary (IC) nitroprusside and intravenous adenosine (IVA) for assessing fractional flow reserve (FFR). Background IV infusion of adenosine is a standard method to achieve a coronary hyperemia for FFR measurement. However, adenosine is expensive, causes multiple side effects, and is contraindicated in patients with reactive airway disease. Sodium nitroprusside (NTP) is a strong coronary vasodilator but its efficacy and safety for assessing FFR is not well established. Methods We compared FFR response and side effects profile of IC NTP and IVA. Bolus of NTP at a dose of 100 μg and IVA (140 μg/kg/min) were used to achieve coronary hyperemia. Results We evaluated 75 lesions in 53 patients (60% male) mean age 61.6 ± 13.9 years. Mean FFR after NTP was similar to FFR after adenosine (0.836 ± 0.107 vs. 0.856 ± 0.106; P = 0.26; r = 0.91, P < 0.001). NTP induced maximal stable hyperemia within 10 sec (mean: 6.4 ± 1) which lasted consistently between 38 and 60 sec (mean 51 ± 7.5). NTP caused significant (14%), but asymptomatic decrease in mean blood pressure which returned to baseline within 60 sec. Adenosine caused shortness of breath in 26%, headache and flushing in 19%, and transient second degree heart block in 6% of patients. No adverse symptoms were reported after NTP. Conclusions IC NTP is as effective as IVA for measuring FFR. NTP is better tolerated by patients. Since NTP is inexpensive, readily available, well tolerated, and safe, it may be a better choice for FFR assessment.Keywords
This publication has 17 references indexed in Scilit:
- Clinical Utility of Regadenoson for Assessing Fractional Flow ReserveJACC: Cardiovascular Interventions, 2011
- Pharmacological options for inducing maximal hyperaemia during studies of coronary physiologyCatheterization and Cardiovascular Interventions, 2008
- Optimum guidance of complex PCI by coronary pressure measurementHeart, 2004
- Coronary Hyperemic Dose Responses of Intracoronary Sodium NitroprussideCirculation, 2004
- Intracoronary and Intravenous Adenosine 5′-Triphosphate, Adenosine, Papaverine, and Contrast Medium to Assess Fractional Flow Reserve in HumansCirculation, 2003
- Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurementsAmerican Heart Journal, 2000
- Measurement of Fractional Flow Reserve to Assess the Functional Severity of Coronary-Artery StenosesThe New England Journal of Medicine, 1996
- Safety profile of adenosine stress perfusion imaging: Results from the adenoscan multicenter trial registryJournal of the American College of Cardiology, 1994
- Intravenous adenosine: Continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery diseaseJournal of the American College of Cardiology, 1991
- Cardiovascular Actions of Sodium Nitroprusside in Animals and Hypertensive PatientsCirculation, 1955